HCA Healthcare: Erica Rossitto sells 3,500 shares

The rights vested in four equal annual installments beginning February 1, 2018, and January 31, 2019, respectively.

Available on EDGAR 11/10/2026 - 05:09 PM EST Accepted by SEC EDGAR 11/10/2026 - 05:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

HCA Healthcare, Inc. executive Erica Rossitto, SVP & Chief Nurse Executive, exercised stock appreciation rights on November 6, 2026, covering 8,080 shares at an $81.96 exercise price and 5,040 shares at a $101.16 exercise price, and acquired corresponding common stock. On that date, 6,601 shares were delivered or withheld for payment of exercise price or tax liability. Rossitto sold 3,500 common shares at $505.8101 per share on November 10, 2026. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Rossitto Erica

Role SVP & Chief Nurse Executive

Sold 3,500 shs ($1.77M)

Approx. gross sale proceeds $1.77M

Approx. exercise cost $1.17M

Share of Position Sold 20.7%

Type	Security	Shares	Price	Value
Sale	Common Stock	3,500	$505.8101	$1.77M
Exercise	Stock Appreciation Right F1	8,080	$0.00	$0.00
Exercise	Stock Appreciation Right F2	5,040	$0.00	$0.00
Exercise	Common Stock	8,080	$81.96	$662K
Exercise	Common Stock	5,040	$101.16	$510K
Exercise Price or Tax Liability	Common Stock	6,601	$494.99	$3.27M

Holdings After Transaction: Stock Appreciation Right — 0 rights (Direct); Common Stock — 13,426 shares (Direct)

Holdings Before and After: Stock Appreciation Right, 13,120 to 0 rights (Direct); Common Stock, 10,407 to 13,426 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
2. F2. The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

Key Figures

Common shares sold: 3,500 shares Sale price per share: $505.8101 per share Stock appreciation rights exercised: 8,080 shares +4 more

7 metrics

Common shares sold 3,500 shares November 10, 2026

Sale price per share $505.8101 per share November 10, 2026

Stock appreciation rights exercised 8,080 shares November 6, 2026; exercise price $81.96 per share

Exercise price $81.96 per share Stock appreciation rights covering 8,080 shares, exercised November 6, 2026

Stock appreciation rights exercised 5,040 shares November 6, 2026; exercise price $101.16 per share

Exercise price $101.16 per share Stock appreciation rights covering 5,040 shares, exercised November 6, 2026

Shares delivered or withheld for payment of exercise price or tax liability 6,601 shares November 6, 2026

Key Terms

Stock appreciation rights, Exercise price, Vested

3 terms

Stock appreciation rights financial

"The stock appreciation rights vested in four equal annual installments"

Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.

Exercise price financial

"payment of exercise price or tax liability"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Vested financial

"vested in four equal annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HCA shares did Erica Rossitto sell, and at what price?

Erica Rossitto sold 3,500 common shares at $505.8101 per share on November 10, 2026. No Rule 10b5-1 plan is reported.

How many HCA shares did Erica Rossitto acquire through stock appreciation rights?

On November 6, 2026, Rossitto acquired 8,080 common shares at $81.96 per share and 5,040 common shares at $101.16 per share in records paired with stock appreciation right exercises. Separately, 6,601 shares were delivered or withheld for payment of exercise price or tax liability.

When did Erica Rossitto's HCA stock appreciation rights vest?

The rights covering 8,080 shares vested in four equal annual installments beginning February 1, 2018. The rights covering 5,040 shares vested in four equal annual installments beginning January 31, 2019.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rossitto Erica

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief Nurse Executive

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/06/2026		M		8,080	A	$81.96	18,487	D
Common Stock	11/06/2026		M		5,040	A	$101.16	23,527	D
Common Stock	11/06/2026		F		6,601	D	$494.99	16,926	D
Common Stock	11/10/2026		S		3,500	D	$505.8101	13,426	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$81.96	11/06/2026		M			8,080	(1)	02/01/2027	Common Stock	8,080	$0.00	0	D
Stock Appreciation Right	$101.16	11/06/2026		M			5,040	(2)	01/31/2028	Common Stock	5,040	$0.00	0	D

Explanation of Responses:

1. The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

2. The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

	/s/ Kevin A. Ball, Attorney-in-Fact	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)